Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy

Ying Wang; Yang Zhang; Qian Yu; Kun Zhu

doi:10.3389/fphar.2020.00966

Frontiers in Pharmacology (Jun 2020)

Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy

Ying Wang,
Yang Zhang,
Qian Yu,
Kun Zhu

Affiliations

Ying Wang: Department of Pharmacy, The Third Hospital of Jilin University, Jilin University, Changchun, China
Yang Zhang: School of Biology and Food Engineering, Changshu Institute of Technology, Changshu, China
Qian Yu: Department of Pharmacy, The Third Hospital of Jilin University, Jilin University, Changchun, China
Kun Zhu: Department of Pharmacy, The Third Hospital of Jilin University, Jilin University, Changchun, China

DOI: https://doi.org/10.3389/fphar.2020.00966
Journal volume & issue: Vol. 11

Abstract

Read online

Given the extreme importance of the current pandemic caused by COVID-19 and due to the fact that scientists agree that there is no identified treatment, this paper analyzes in detail the treatment of a severe COVID-19 patient with convalescent plasma and drugs based on current guidelines for COVID-19 diagnosis and treatment. This can provide a reference for other medical institutions on rational drug use and pharmaceutical care for severe COVID-19 patients.

Published in Frontiers in Pharmacology

ISSN: 1663-9812 (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Therapeutics. Pharmacology
Website: http://journal.frontiersin.org/journals/pharmacology

About the journal

Abstract

Keywords